{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:35:06Z","timestamp":1791282906116,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"COMpAAAS\/Veterans Aging Cohort Study\u00a0"},{"name":"CHAART Cooperative Agreement"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health,","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"crossref","award":["U24-AA020794"],"award-info":[{"award-number":["U24-AA020794"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"crossref","award":["U01-AA020790"],"award-info":[{"award-number":["U01-AA020790"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"crossref","award":["U01-AA020795"],"award-info":[{"award-number":["U01-AA020795"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"crossref","award":["U01-AA020799"],"award-info":[{"award-number":["U01-AA020799"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"crossref","award":["U10-AA013566"],"award-info":[{"award-number":["U10-AA013566"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["U01-HL142103"],"award-info":[{"award-number":["U01-HL142103"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["R01-CA243907"],"award-info":[{"award-number":["R01-CA243907"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Nicotine replacement therapy, bupropion, and varenicline are smoking cessation medications (SCMs) shown to be similarly effective in people with and without human immunodeficiency virus (PWH and PWoH, respectively), although rates of receipt of these medications are unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We identified patients in the Veterans Aging Cohort Study with electronic health record-documented current smoking using clinical reminder data for tobacco use (2003\u20132018). We measured receipt of SCMs using Veterans Affairs pharmacy data for outpatient prescriptions filled 0\u2013365 days after current smoking documentation. We used log-linear, Poisson-modified regression models to evaluate the relative risk (RR) for receiving SCM by human immunodeficiency virus (HIV) status, the annual rate of receipt, and rate difference among PWH relative to PWoH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The sample included 92 632 patients (29 086 PWH), reflecting 381 637 documentations of current smoking. From 2003 to 2018, the proportion receiving SCMs increased from 15% to 34% for PWH and from 17% to 32% among PWoH. There was no statistical difference in likelihood of receiving SCM by HIV status (RR, 1.010; 95% confidence interval [CI], .994\u20131.026). Annual rates of receiving SCM increased for PWH by 4.3% per year (RR, 1.043; 95% CI, 1.040\u20131.047) and for PWoH by 3.7% per year (RR, 1.037; 95% CI, 1.036\u20131.038; rate difference +0.6% [RR, 1.006; 95% CI, 1.004\u20131.009]).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In a national sample of current smokers, receipt of SCM doubled over the 16-year period, and differences by HIV status were modest. However, fewer than 35% of current smokers receive SCM annually. Efforts to improve SCM receipt should continue for both groups given the known dangers of smoking.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ofid\/ofad089","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T19:42:45Z","timestamp":1676922165000},"source":"Crossref","is-referenced-by-count":4,"title":["Receipt of Smoking Cessation Medications Among People With and Without Human Immunodeficiency Virus in the Veterans Aging Cohort Study (2003\u20132018)"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5578-854X","authenticated-orcid":false,"given":"Shahida","family":"Shahrir","sequence":"first","affiliation":[{"name":"Department of Health Systems and Population Health, University of Washington School of Public Health , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Crothers","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, VA Puget Sound Health Care System and University of Washington , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A","family":"McGinnis","sequence":"additional","affiliation":[{"name":"Veterans Affairs CT Healthcare System , West Haven, Connecticut , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwun C G","family":"Chan","sequence":"additional","affiliation":[{"name":"Departments of Biostatistics and Health Systems and Population Health, University of Washington School of Public Health , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared M","family":"Baeten","sequence":"additional","affiliation":[{"name":"Departments of Global Health, Medicine and Epidemiology, University of Washington School of Public Health , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham Veterans Affairs Healthcare System , Durham, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel A","family":"Butt","sequence":"additional","affiliation":[{"name":"VA Pittsburgh Healthcare System , Pittsburgh, Pennsylvania , USA"},{"name":"Departments of Medicine and Population Health Sciences , Weill Cornell Medicine, New York, New York , USA"},{"name":"Corporate Quality and Patient Safety Department, Hamad Medical Corporation Doha Qatar , Doha , Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A","family":"Pisani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine , New Haven, Connecticut , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R","family":"Baldassarri","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine , New Haven, Connecticut , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0139-5502","authenticated-orcid":false,"given":"Amy","family":"Justice","sequence":"additional","affiliation":[{"name":"Veterans Affairs CT Healthcare System , West Haven, Connecticut , USA"},{"name":"Departments of Internal Medicine and Health Policy and Management, Yale University Schools of Medicine and Public Health , New Haven, Connecticut , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Health Systems and Population Health, University of Washington School of Public Health , Seattle, Washington , USA"},{"name":"Center of Innovation for Veteran-Centered and Value-Driven Care, VA Puget Sound Health Services Research & Development , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/QAD.0000000000000540","article-title":"Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America","volume":"29","author":"Helleberg","year":"2015","journal-title":"AIDS"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/ntr\/ntaa277","article-title":"National estimates of prevalence, time-trend, and correlates of smoking in US people living with HIV (NHANES 1999\u20132016)","volume":"23","author":"Asfar","year":"2021","journal-title":"Nicotine Tob Res"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M14-0954","article-title":"Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys","volume":"162","author":"Mdodo","year":"2015","journal-title":"Ann Intern Med"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.15585\/mmwr.mm6946a4","article-title":"Tobacco product use among adults\u2014United States, 2019","volume":"69","author":"Cornelius","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.amepre.2008.04.009","article-title":"A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public health service report","volume":"35","author":"Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff","year":"2008","journal-title":"Am J Prev Med"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1157\/13092468","article-title":"[Bupropion use for smoking cessation in HIV-infected patients receiving antiretroviral therapy]","volume":"24","author":"Pedrol-Clotet","year":"2006","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/apc.2011.0199","article-title":"Safety and tolerability of varenicline tartrate (Champix((R))\/Chantix((R))) for smoking cessation in HIV-infected subjects: a pilot open-label study","volume":"26","author":"Cui","year":"2012","journal-title":"AIDS Patient Care STDS"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/ntr\/ntt005","article-title":"A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings","volume":"15","author":"Humfleet","year":"2013","journal-title":"Nicotine Tob Res"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pcad.2020.01.003","article-title":"Receipt and predictors of smoking cessation pharmacotherapy among veterans with and without HIV","volume":"63","author":"Shahrir","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ahj.2005.07.030","article-title":"Cardiovascular disease in HIV infection","volume":"151","author":"Sudano","year":"2006","journal-title":"Am Heart J"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.2105\/AJPH.2009.188664","article-title":"Smoking-related health risks among persons with HIV in the strategies for management of antiretroviral therapy clinical trial","volume":"100","author":"Lifson","year":"2010","journal-title":"Am J Public Health"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/0003-4819-132-5-200003070-00006","article-title":"Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers","volume":"132","author":"Diaz","year":"2000","journal-title":"Ann Intern Med"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1378\/chest.130.5.1326","article-title":"Increased COPD among HIV-positive compared to HIV-negative veterans","volume":"130","author":"Crothers","year":"2006","journal-title":"Chest"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/518606","article-title":"HIV Infection is associated with an increased risk for lung cancer, independent of smoking","volume":"45","author":"Kirk","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/QAD.0b013e328352d1ad","article-title":"HIV As an independent risk factor for incident lung cancer","volume":"26","author":"Sigel","year":"2012","journal-title":"AIDS"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1001\/jama.283.24.3244","article-title":"A clinical practice guideline for treating tobacco use and dependence: a US public health service report. The tobacco use and dependence clinical practice guideline panel, staff, and consortium representatives","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1007\/s10461-017-1717-6","article-title":"Veterans living with HIV: a high-risk group for cigarette smoking","volume":"21","author":"Wilson","year":"2017","journal-title":"AIDS Behav"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7205\/MILMED-D-00-3108","article-title":"Evidence-based national initiatives to address tobacco use as a public health priority in the Veterans Health Administration","volume":"174","author":"Hamlett-Berry","year":"2009","journal-title":"Mil Med"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.mlr.0000223670.00890.74","article-title":"Development and verification of a \u201cvirtual\u201d cohort using the National VA Health Information System","volume":"44","author":"Fultz","year":"2006","journal-title":"Med Care"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.mlr.0000223741.02074.66","article-title":"Veterans Aging Cohort Study (VACS): overview and description","volume":"44","author":"Justice","year":"2006","journal-title":"Med Care"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/ntr\/ntr206","article-title":"Validating smoking data from the Veteran's Affairs health factors dataset, an electronic data source","volume":"13","author":"McGinnis","year":"2011","journal-title":"Nicotine Tob Res"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/NAQ.0000000000000118","article-title":"The Veterans Affairs's Corporate data warehouse: uses and implications for nursing research and practice","volume":"39","author":"Price","year":"2015","journal-title":"Nurs Adm Q"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.clpt.6100027","article-title":"Lopinavir\/ritonavir reduces bupropion plasma concentrations in healthy subjects","volume":"81","author":"Hogeland","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/COPD.S1121","article-title":"The use of bupropion SR in cigarette smoking cessation","volume":"3","author":"Wilkes","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2023032309172500100_","volume-title":"HIV Provider Smoking Cessation Handbook: A Resource for Providers","author":"U.S. Department of Veterans Affairs, V.H.A., Clinical Public Health","year":"2012"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108128","article-title":"Smoking and cessation treatment among persons with and without HIV in a U. S. Integrated health system","volume":"213","author":"Lam","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/01612840.2012.692463","article-title":"Adverse neuropsychiatric events associated with varenicline use in veterans: a case series","volume":"33","author":"Cantrell","year":"2012","journal-title":"Issues Ment Health Nurs"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2015.19284","article-title":"Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks: a randomized clinical trial","volume":"315","author":"Baker","year":"2016","journal-title":"JAMA"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamapsychiatry.2013.678","article-title":"Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal","volume":"70","author":"Cinciripini","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"key":"2023032309172500100_","first-page":"S28","article-title":"Social conditions as fundamental causes of disease","author":"Link","year":"2010","journal-title":"J Health Soc Behav"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2105\/AJPH.2007.114777","article-title":"Transcending the known in public health practice: the inequality paradox: the population approach and vulnerable populations","volume":"98","author":"Frohlich","year":"2008","journal-title":"Am J Public Health"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/16066359.2014.920013","article-title":"A review of the literature concerning HIV and cigarette smoking: morbidity and mortality, associations with individual- and social-level characteristics, and smoking cessation efforts","volume":"23","author":"Pacek","year":"2015","journal-title":"Addict Res Theory"},{"key":"2023032309172500100_","first-page":"1045","article-title":"Characteristics associated with HIV infection among heterosexuals in urban areas with high AIDS prevalence\u201424 cities, United States, 2006\u20132007","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ypmed.2018.03.007","article-title":"Trends in cigarette smoking among adults with HIV compared with the general adult population, United States-2009\u20132014","volume":"111","author":"Frazier","year":"2018","journal-title":"Prev Med"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1525-1497.1999.00335.x","article-title":"Dual use of VA and non-VA primary care","volume":"14","author":"Borowsky","year":"1999","journal-title":"J Gen Intern Med"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/00005650-199807000-00014","article-title":"Private health insurance and veterans use of veterans affairs care. RATE project committee. Rate alternative technical evaluation","volume":"36","author":"Kashner","year":"1998","journal-title":"Med Care"},{"key":"2023032309172500100_","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/00005650-198512000-00005","article-title":"Veterans\u2019 and nonveterans\u2019 use of health services. A comparative analysis","volume":"23","author":"Wolinsky","year":"1985","journal-title":"Med Care"},{"key":"2023032309172500100_","first-page":"1058","article-title":"Pharmacy benefits management in the Veterans Health Administration revisited: a decade of advancements, 2004\u20132014","volume":"22","author":"Aspinall","year":"2016","journal-title":"J Manag Care Spec Pharm"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad089\/49280473\/ofad089.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/3\/ofad089\/49601415\/ofad089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/3\/ofad089\/49601415\/ofad089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T21:43:28Z","timestamp":1679780608000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad089\/7048933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad089","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2023,2,20]]},"article-number":"ofad089"}}